Using Synthetic MRI and Radiomics to Predict Treatment Response in Triple-Negative Breast Cancer.
作者信息
Houser Margaret, Rapelyea Jocelyn A
机构信息
From the Department of Radiology, The George Washington University School of Medicine and Health Sciences, 2150 Pennsylvania Ave NW, Washington, DC 20037.
出版信息
Radiol Imaging Cancer. 2023 Jul;5(4):e230095. doi: 10.1148/rycan.230095.
Abstract
摘要
相似文献
1
Using Synthetic MRI and Radiomics to Predict Treatment Response in Triple-Negative Breast Cancer.
Radiol Imaging Cancer. 2023 Jul;5(4):e230095. doi: 10.1148/rycan.230095.
2
Radiomics features based on automatic segmented MRI images: Prognostic biomarkers for triple-negative breast cancer treated with neoadjuvant chemotherapy.
Eur J Radiol. 2022 Jan;146:110095. doi: 10.1016/j.ejrad.2021.110095. Epub 2021 Dec 4.
3
Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Breast Cancer Res. 2017 May 18;19(1):57. doi: 10.1186/s13058-017-0846-1.
4
Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set.
Breast Cancer Res Treat. 2019 Jan;173(2):455-463. doi: 10.1007/s10549-018-4990-9. Epub 2018 Oct 16.
5
Multicontrast MRI-based radiomics for the prediction of pathological complete response to neoadjuvant chemotherapy in patients with early triple negative breast cancer.
MAGMA. 2021 Dec;34(6):833-844. doi: 10.1007/s10334-021-00941-0. Epub 2021 Jul 13.
6
A pilot study of radiomics technology based on X-ray mammography in patients with triple-negative breast cancer.
J Xray Sci Technol. 2019;27(3):485-492. doi: 10.3233/XST-180488.
7
MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
Acad Radiol. 2022 Jan;29 Suppl 1(Suppl 1):S145-S154. doi: 10.1016/j.acra.2020.10.020. Epub 2020 Nov 5.
8
Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer.
Cell Rep Med. 2022 Jul 19;3(7):100694. doi: 10.1016/j.xcrm.2022.100694.
9
Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer.
J Transl Med. 2022 Oct 15;20(1):471. doi: 10.1186/s12967-022-03688-x.
10
MRI-based radiomics for the diagnosis of triple-negative breast cancer: a meta-analysis.
Clin Radiol. 2022 Sep;77(9):655-663. doi: 10.1016/j.crad.2022.04.015. Epub 2022 May 28.
引用本文的文献
1
A 20-feature radiomic signature of triple-negative breast cancer identifies patients at high risk of death.
NPJ Breast Cancer. 2025 Jul 26;11(1):79. doi: 10.1038/s41523-025-00790-3.
本文引用的文献
1
A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast Cancer.
Radiol Imaging Cancer. 2023 Jul;5(4):e230009. doi: 10.1148/rycan.230009.
2
Predicting of Ki-67 Expression Level Using Diffusion-Weighted and Synthetic Magnetic Resonance Imaging in Invasive Ductal Breast Cancer.
Breast J. 2023 Apr 5;2023:6746326. doi: 10.1155/2023/6746326. eCollection 2023.
3
Deep Learning to Simulate Contrast-enhanced Breast MRI of Invasive Breast Cancer.
Radiology. 2023 Mar;306(3):e213199. doi: 10.1148/radiol.213199. Epub 2022 Nov 15.
4
Utility of synthetic MRI in predicting pathological complete response of various breast cancer subtypes prior to neoadjuvant chemotherapy.
Clin Radiol. 2022 Nov;77(11):855-863. doi: 10.1016/j.crad.2022.06.019. Epub 2022 Aug 30.
5
Investigating the Image Quality and Utility of Synthetic MRI in the Breast.
Magn Reson Med Sci. 2021 Dec 1;20(4):431-438. doi: 10.2463/mrms.mp.2020-0132. Epub 2021 Feb 2.
6
Improved discrimination of molecular subtypes in invasive breast cancer: Comparison of multiple quantitative parameters from breast MRI.
Magn Reson Imaging. 2021 Apr;77:148-158. doi: 10.1016/j.mri.2020.12.001. Epub 2020 Dec 9.
7
Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis.
Clin Cancer Res. 2020 Jun 15;26(12):2838-2848. doi: 10.1158/1078-0432.CCR-19-3492. Epub 2020 Feb 11.
8
Synthetic MRI for Clinical Neuroimaging: Results of the Magnetic Resonance Image Compilation (MAGiC) Prospective, Multicenter, Multireader Trial.
AJNR Am J Neuroradiol. 2017 Jun;38(6):1103-1110. doi: 10.3174/ajnr.A5227. Epub 2017 Apr 27.
9
Incidentally detected enhancing lesions found in breast MRI: analysis of apparent diffusion coefficient and T2 signal intensity significantly improves specificity.
Eur Radiol. 2016 Dec;26(12):4361-4370. doi: 10.1007/s00330-016-4326-2. Epub 2016 Apr 25.
10
Lesion T(2) relaxation times and volumes predict the response of malignant breast lesions to neoadjuvant chemotherapy.
Magn Reson Imaging. 2008 Jan;26(1):26-34. doi: 10.1016/j.mri.2007.04.002. Epub 2007 Jun 15.
Zotero 插件